版本:
中国

BRIEF-GSK still in talks with AstraZeneca about start date for Luke Miels

April 26 GlaxoSmithKline Plc CEO Emma Walmsley told analysts:

* "no comment" on whether would launch authorised advair generic in u.s.

* still in discussion with AstraZeneca about date for Luke Miels to join GSK Further company coverage: (Reporting by UK bureau)

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐